Answers are grounded in this paper and cite their sources.
Simarouba glauca leaves are rich in quassinoids, known for anticancer properties. This study aimed to develop a lipid-based solid dispersion of the quassinoid-enriched fraction (LBSD-QEF) to enhance permeability in MCF7 breast cancer cells. LBSD-QEF of SG was prepared by hot homogenization using soy lecithin and Pluronic F68 (1:2) with varying concentrations of SGQEF. Out of the six developed formulations, the F5 (LBSD-QEF of SG) was chosen as the best one based on the zeta potential (-33.2 mV), polydispersity index (0.413), and an average mean particle size (275 nm). It comprises 50 mg of SG quassinoid enriched fraction in addition to 1:2 ratio of lipid (12.5 mg) and surfactant (25 mg). F5 remained stable for 3 months at 4 ± 2.0°C/50 % ± 5 % RH. In vitro drug release F5 (LBSD-QEF of SG) showed 76 % quassinoid release in the first hour and 80 % in the second through dialysis membrane. Cellular uptake of F5 in Caco-2 cells demonstrated strong FITC signal expression. Cytotoxicity studies showed F5 had an IC₅₀ of 12.45 µg/ml against MCF7 cells, outperforming SGQEF (IC₅₀ = 35.05 µg/ml) and crude methanol extract (IC₅₀ = 49.19 µg/ml). The developed F5 (LBSD-QEF of Simarouba glauca ) enhances membrane permeability and exhibits greater cytotoxicity in ER+ breast cancer cells.
No takes yet. Share an insight, caveat, or question.
Subburaj et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: